12 Health Care Stocks Moving In Wednesday's Pre-Market Session
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript Summary
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $14 Price Target
CollPlant Biotechnologies Analyst Ratings
Collplant Biotechnologies' Cash And Cash Equivalents As Of September 30, 2024 Were $15.4M, Expected To Provide Cash Runway Until The End Of 2025
CollPlant Biotechnologies Q3 2024 Adj EPS $(0.33) Misses $(0.28) Estimate, Sales $4.00K May Not Be Comparable To $416.00K Estimate